D-0574-2016 Class III Terminated
FDA drug recall D-0574-2016 was initiated by PD-Rx Pharmaceuticals, Inc. on Jul 21, 2015 and is designated Class III. Reason for recall: Failed impurities/Degradation specifications: out of specification results for individual unknown and total impurity at the 12th month room temperature stability test station The recall status is terminated (terminated Dec 23, 2016). Affected quantity: 1685 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 27, 2016
- Initiation Date
- Jul 21, 2015
- Termination Date
- Dec 23, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1685 bottles
Product description
Phentermine Hydrochloride Capsules, USP, 15 mg, packaged in a) 7-count (NDC 55289-791-07), b) 14-count (NDC 55289-791-14), c) 28-count (NDC 55289-791-28), d) 30-count (NDC 55289-791-30), and e) 60-count (NDC 55289-791-60) bottles, Packaged by PD-RX Pharmaceuticals, INC Oklahoma City, OK 73127, MFG: KVK-TECH, INC Newtown, PA 18840.
Reason for recall
Failed impurities/Degradation specifications: out of specification results for individual unknown and total impurity at the 12th month room temperature stability test station
Distribution pattern
Nationwide
Code information
Lot #: a) H14C80, Exp 08/16; I14G36, Exp 09/16; b) H14A86, Exp 07/16; c) H14C83, Exp 08/16, K14A21, Exp 11/16; d) H14F25, Exp 08/16; e) L14C42, Exp 12/16.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0574-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026